A comparative proteomic profiling of the human erythrocyte membrane in COPD patients

C. Lopes, B. Alexandre, N. Charro, P. Azevedo, A. Bugalho-Almeida, K. Chan, H. Issaq, T. Veenstra, J. Blonder, D. Penque (Lisbon, Portugal; Frederick, United States Of America)

Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Session: New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Session type: Thematic Poster Session
Number: 849
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Lopes, B. Alexandre, N. Charro, P. Azevedo, A. Bugalho-Almeida, K. Chan, H. Issaq, T. Veenstra, J. Blonder, D. Penque (Lisbon, Portugal; Frederick, United States Of America). A comparative proteomic profiling of the human erythrocyte membrane in COPD patients. Eur Respir J 2009; 34: Suppl. 53, 849

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Transcriptome profiling of platelets from patients with severe asthma.
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

The landscape of transcriptomic and proteomic studies in sarcoidosis
Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021
Year: 2022



Association between microbiome and plasma proteome profile in COPD
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006

Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012


COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes
Source: ERJ Open Res, 7 (3) 00915-2020; 10.1183/23120541.00915-2020
Year: 2021



Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018




iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011


Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Identification of disease genes by expression profiling
Source: Eur Respir J 2001; 18: 882-889
Year: 2001



Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005

Training-induced effects on plasma metabolomics in patients with COPD
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008